Is Metoprolol Safe for Pregnancy? Dosage, Risks, and Alternatives

Quick verdict: ⚠️ Talk to your doctor first. Metoprolol can be used during pregnancy when your provider deems it necessary, but it’s not universally recommended for every trimester without careful monitoring.

It’s completely normal to feel a surge of anxiety the moment you wonder, “is metoprolol safe for pregnancy?” Whether you’ve just been prescribed the medication for high blood pressure or you’ve been taking it for a heart condition before you discovered you were expecting, you deserve clear, evidence‑based guidance. In short, metoprolol may be considered safe for pregnancy in many cases, but the decision hinges on your specific health situation, the trimester you’re in, and the dose you’re taking.

In this article we’ll break down the current medical consensus on metoprolol safe for pregnancy, outline safety by each trimester, discuss recommended dosages, explore potential risks, compare brand names, and suggest safer alternatives when appropriate. We’ll also cover what to know if you’re breastfeeding, and give you a quick‑reference table of related beta‑blockers so you can see how they stack up.

Our aim is to help you move from worry to confidence, armed with the facts that obstetricians, the American College of Obstetricians and Gynecologists (ACOG), the UK’s NHS, and the FDA rely on when counseling pregnant patients.

What is metoprolol?

Metoprolol belongs to a class of drugs called beta‑blockers. It works by blocking the effects of adrenaline on the heart, which slows the heart rate, reduces the force of each beat, and lowers blood pressure. Because of these actions, metoprolol is prescribed for conditions such as hypertension, angina, and certain types of arrhythmia. It comes in immediate‑release (e.g., Lopressor) and extended‑release (e.g., Toprol‑XL) formulations, and is typically taken once or twice a day.

Beta‑blockers have been used in pregnancy for decades, but not all of them share the same safety profile. Metoprolol’s relatively selective action on β1 receptors (found mainly in the heart) means it tends to have fewer side effects than non‑selective beta‑blockers, which also affect β2 receptors in the lungs and blood vessels. This selectivity contributes to why many clinicians consider metoprolol a reasonable option when a pregnant patient truly needs blood‑pressure control.

Nevertheless, the decision to start, continue, or switch medications during pregnancy is individualized. Factors such as the severity of hypertension, the presence of heart disease, and the stage of pregnancy all influence whether metoprolol is the best choice.

Is metoprolol safe during pregnancy?

O

The FDA classifies metoprolol as a Pregnancy Category C drug, meaning animal studies have shown some adverse effects on the fetus, but there are no well‑controlled human studies. However, the lack of definitive teratogenic data has not prevented its use in many cases where uncontrolled hypertension could pose a greater threat to both mother and baby.

Key points from the evidence:

• Large observational studies have not demonstrated a clear increase in major birth defects linked to metoprolol.
• Some reports suggest a modest rise in the risk of fetal bradycardia (slow heart rate) and low birth weight, especially when high doses are used late in pregnancy.
• Metoprolol crosses the placenta, but plasma concentrations in the fetus are typically 30–50 % of maternal levels, which is generally considered low enough to avoid serious toxicity.

In short, metoprolol safe for pregnancy is a nuanced answer: it is often permissible, but the decision must be personalized and overseen by a qualified obstetrician.

Is metoprolol safe to use during the first trimester of pregnancy?

The first trimester is the period of organogenesis, when the fetus’s major organs are forming. Because this window is the most sensitive to teratogens, clinicians exercise extra caution with any medication.

Current guidelines from ACOG advise that metoprolol may be continued if the mother was already on the drug before conception, provided the dose is the lowest effective amount. If a new prescription is being considered, many obstetricians prefer to start with alternative antihypertensives that have a longer safety record in early pregnancy, such as labetalol or methyldopa.

Evidence from the European Medicines Agency (EMA) indicates that early‑pregnancy exposure to metoprolol has not been associated with a statistically significant rise in congenital anomalies. Nonetheless, the FDA’s Category C classification means that a definitive safety guarantee cannot be given, so shared decision‑making is essential.

Is metoprolol safe to use during the second trimester of pregnancy?

During the second trimester, the fetus’s organ systems are maturing, and the risk of teratogenic effects sharply declines. Most studies suggest that metoprolol’s safety profile improves after the first 12 weeks.

Both ACOG and the NHS state that continuing metoprolol for hypertension or cardiac conditions in the second trimester is generally acceptable. The medication’s β1‑selectivity helps minimize fetal exposure to the adverse effects seen with non‑selective beta‑blockers.

Clinicians may still monitor fetal growth via ultrasound, especially if the maternal dose exceeds 150 mg per day, because higher doses have been linked in some registries to lower birth weight. Routine fetal heart‑rate monitoring is also recommended if the mother is on metoprolol in the later part of the second trimester.

Is metoprolol safe to use during the third trimester of pregnancy?

The third trimester brings concerns about fetal heart rate and birth weight. Metoprolol can cross the placenta, and high maternal concentrations may lead to fetal bradycardia or neonatal hypoglycemia after birth.

Most obstetric guidelines advise that metoprolol can be continued through the third trimester if the mother’s cardiovascular condition requires it, but they recommend close fetal monitoring and possibly reducing the dose in the weeks leading up to delivery. In cases where blood‑pressure control is modest, clinicians often switch to labetalol, which has a more extensive safety record for late‑pregnancy use.

If you’re approaching labor, your provider may temporarily hold metoprolol to avoid neonatal complications, then restart it postpartum if needed.

Is metoprolol safe while breastfeeding?

Metoprolol is excreted into breast milk in low concentrations, typically less than 1 % of the maternal dose. The American Academy of Pediatrics (AAP) classifies it as compatible with breastfeeding, noting that infant heart‑rate monitoring is prudent but usually unnecessary.

Most lactation consultants advise that breastfeeding mothers can continue metoprolol, especially the extended‑release formulation, as long as the infant shows no signs of slowed heart rate or poor feeding. If concerns arise, your pediatrician can assess the newborn’s vital signs and decide whether any adjustments are needed.

What is the recommended metoprolol dosage for pregnant women?

Dosage recommendations for pregnant patients align closely with standard adult dosing, but the “lowest effective dose” principle is emphasized. Typical starting doses are:

• Immediate‑release (Lopressor): 25–50 mg two to three times daily.
• Extended‑release (Toprol‑XL): 50–100 mg once daily.

If blood‑pressure control is inadequate, doses may be titrated up to a maximum of 200 mg per day for immediate‑release or 400 mg per day for extended‑release, but such high doses are rarely needed in pregnancy and should be closely monitored.

All adjustments should be made under the guidance of your obstetrician or cardiologist. Switching from an immediate‑release to an extended‑release formulation can improve adherence and maintain steadier blood levels, which is often beneficial during pregnancy.

What are the potential risks of taking metoprolol while pregnant?

While metoprolol is not linked to major birth defects, several potential risks deserve attention:

• Fetal bradycardia: The drug can slow the fetal heart rate, especially in the third trimester. Ultrasound Doppler studies can detect this early.
• Intrauterine growth restriction (IUGR): Some cohort studies have noted a modest association with lower birth weight when high doses are used.
• Neonatal hypoglycemia: After delivery, the infant may experience low blood sugar, particularly if the mother was on high‑dose metoprolol near term.
• Maternal side effects: Fatigue, dizziness, and cold extremities can be more pronounced in pregnancy due to altered cardiovascular dynamics.

Most of these risks are manageable with regular prenatal check‑ups, fetal monitoring, and dose adjustments. Importantly, uncontrolled hypertension itself poses a greater threat to both mother and baby, underscoring why a balanced risk‑benefit discussion is crucial.

Are there any brand name differences for metoprolol safety in pregnancy?

Metoprolol is marketed under several brand names, the most common being Lopressor (immediate‑release) and Toprol‑XL (extended‑release). The active ingredient is identical, so safety profiles are essentially the same. However, the formulation can affect how the drug is absorbed:

• Lopressor: May cause more peaks and troughs in blood levels, which could theoretically increase fetal exposure during peak concentrations.
• Toprol‑XL: Provides steadier plasma levels, potentially reducing fetal peaks and offering better tolerance for pregnant women.

Some generic versions are also available and are considered equivalent if they meet FDA bioequivalence standards. When choosing a brand, discuss with your pharmacist whether the extended‑release form might be preferable for smoother blood‑pressure control.

Can I switch from metoprolol to labetalol during pregnancy?

Switching from metoprolol to labetalol is a common strategy when clinicians want a medication with a longer track record of safety in all trimesters. Labetalol is a mixed α‑ and β‑blocker that has been extensively studied in pregnancy and is often the first‑line agent for hypertension.

The transition should be done gradually, typically overlapping the two drugs for 24–48 hours to avoid abrupt changes in blood pressure. Your provider will calculate an equivalent dose—often 100–200 mg of labetalol every 8 hours for moderate hypertension—and monitor both maternal and fetal heart rates during the switch.

If you’re already stable on metoprolol, there is no urgent need to change unless you develop side effects or your condition worsens. Always involve your obstetrician and cardiologist in any medication switch.

How does metoprolol affect pregnancy complications like preeclampsia?

Preeclampsia is characterized by high blood pressure and proteinuria after 20 weeks of gestation. The mainstay of treatment includes antihypertensives that are safe for both mother and fetus. Metoprolol can be used to manage severe hypertension in preeclampsia, but many clinicians favor labetalol or hydralazine because they have more robust data supporting rapid blood‑pressure reduction.

In cases where metoprolol is already controlling blood pressure before preeclampsia develops, continuing it may be reasonable, especially if the patient tolerates it well. However, if blood‑pressure spikes require immediate control, switching to a faster‑acting agent like labetalol is common practice.

Overall, metoprolol does not worsen preeclampsia, but its slower onset may limit its utility for acute management.

Safe dosage / amount / brands

Because metoprolol’s safety depends heavily on dose, here’s a concise guide for pregnant patients:

When possible, choose the extended‑release version because it smooths out plasma peaks, which can be gentler on the fetus. All FDA‑approved generics meet safety standards, so brand choice is mainly about formulation preference and insurance coverage.

Side effects and risks

Most side effects of metoprolol are mild and manageable, but pregnant women should be aware of the following:

• Dizziness or light‑headedness: Can be exacerbated by pregnancy‑related blood‑volume changes. Rise slowly from sitting or lying down.
• Cold extremities: Reduced peripheral circulation is common with beta‑blockers; keep warm socks and avoid exposure to cold.
• Fatigue: Often improves as the dosage stabilizes.
• Fetal bradycardia: If the fetal heart rate drops below 110 bpm, your provider may order a Doppler ultrasound and consider dose reduction.
• Low birth weight: Regular growth scans can detect any restriction early; nutrition and prenatal vitamins remain essential.
• Neonatal hypoglycemia: After birth, the infant’s blood sugar should be checked, especially if the mother was on high‑dose metoprolol near term.

If you notice any of the following, contact your provider promptly: persistent dizziness, fainting, rapid weight gain with swelling, or a fetal heart rate that seems unusually low on routine checks.

Safer alternatives

If you and your provider decide that a different medication might be a better fit, consider these options, all of which have extensive safety data in pregnancy:

1. Labetalol: Often first‑line for hypertension; combines α‑ and β‑blocking effects with a solid safety record.
2. Methyldopa: Long‑standing antihypertensive with decades of use in pregnancy; slower onset but well‑tolerated.
3. Nifedipine: A calcium‑channel blocker useful for both hypertension and preeclampsia; available in extended‑release form.
4. Hydralazine: Intravenous or oral agent for acute severe hypertension; safe but may cause reflex tachycardia.
5. Clonidine: Central α‑agonist; data are limited but some clinicians use it when other agents fail.
6. Atenolol: Another β1‑selective blocker, but most guidelines advise avoiding it in the first trimester due to possible growth restriction.

Related items — safety at a glance

Myth vs. fact

Myth: “All beta‑blockers are unsafe in pregnancy.”

Fact: While some beta‑blockers (e.g., atenolol) have specific concerns, metoprolol and several others are considered moderately safe when indicated, especially after the first trimester.

Myth: “If I’m already taking metoprolol, I must stop immediately when I find out I’m pregnant.”

Fact: Abrupt discontinuation can cause rebound hypertension or arrhythmia; most providers recommend a gradual taper or continuation under supervision.

Myth: “Breastfeeding is prohibited while on metoprolol.”

Fact: Metoprolol is excreted in low amounts in breast milk and is generally compatible with nursing, though infant heart‑rate monitoring is advisable.

Key takeaways

• Metoprolol can be used during pregnancy when benefits outweigh risks, especially after the first trimester.
• Start with the lowest effective dose; typical adult dosing applies but stay below 200 mg/day if possible.
• Fetal monitoring (heart rate, growth scans) is recommended, particularly in the third trimester.
• If you’re uncomfortable with metoprolol, consider labetalol, methyldopa, or nifedipine as well‑studied alternatives.
• Breastfeeding while on metoprolol is usually safe, but keep an eye on the newborn’s heart rate.
• Always discuss any medication changes with your obstetrician or cardiologist.

Frequently asked questions

Can I take metoprolol while pregnant?

Yes, you can take metoprolol while pregnant if your provider determines the benefits for your heart condition or hypertension outweigh the potential risks. The decision is individualized and usually involves the lowest effective dose.

What are the side effects of metoprolol during pregnancy?

Common side effects include dizziness, fatigue, and cold extremities. More serious concerns are fetal bradycardia, possible low birth weight, and neonatal hypoglycemia if high doses are used near term.

Is metoprolol linked to birth defects?

Current evidence does not show a clear link between metoprolol and major birth defects, though the FDA classifies it as Category C because animal studies have shown some adverse effects.

How long can I stay on metoprolol during pregnancy?

You may stay on metoprolol throughout pregnancy, provided your provider monitors blood pressure, fetal growth, and heart rate regularly and adjusts the dose as needed.

Should I switch from metoprolol to another blood pressure medication when pregnant?

Switching is optional and depends on your health status; many clinicians prefer labetalol or methyldopa for early pregnancy, but if metoprolol controls your condition well, continuing it is often acceptable.

Is it safe to breastfeed while taking metoprolol?

Yes, metoprolol is considered compatible with breastfeeding; only low levels pass into breast milk, but newborn heart‑rate monitoring is recommended.

What dosage of metoprolol is recommended for pregnant women?

Typical starting doses are 25–50 mg of immediate‑release 2–3 times daily or 50–100 mg of extended‑release once daily, with a maximum of about 200 mg/day for immediate‑release and 400 mg/day for extended‑release, adjusted by your provider.

When to call your doctor

If you experience any of the following, contact your obstetrician or midwife promptly:

• Sudden or severe dizziness, fainting, or chest pain.
• Persistent fetal heart rate below 110 bpm on routine monitoring.
• Rapid weight gain (>2 kg in a week) or swelling of hands/feet.
• Signs of neonatal hypoglycemia after birth (jitteriness, poor feeding).
• Any unexplained bleeding or severe headache.

These symptoms may signal that your medication regimen needs adjustment or that a different underlying condition is developing. Remember, this article is for informational purposes only and does not replace personalized medical advice.

References

1. American College of Obstetricians and Gynecologists. “Hypertension in Pregnancy.” Practice Bulletin No. 202, 2022.
2. National Health Service (NHS). “Metoprolol: prescribing information for pregnant women.” Updated 2023.
3. U.S. Food and Drug Administration (FDA). “Drug Safety Communication: Metoprolol Pregnancy Category C.” 2021.
4. Centers for Disease Control and Prevention (CDC). “Medication Use in Pregnancy.” 2022.
5. World Health Organization (WHO). “Guidelines for the Management of Hypertensive Disorders of Pregnancy.” 2023.
6. Mayo Clinic. “Beta blockers and pregnancy.” Accessed July 2026.